Skip to content

CleanSpark

US · CLSK #2456 by market cap Listed 1970
11.52 -0.77 -6.27%
Live - 5344 symbols - heartbeat 327s ago · 2026-10-08 07:00
Pre-market 11.34 -1.56%
After-hours 11.57 +0.43%
Overnight 11.35 -1.48%
Market cap
2.96B
P/B
3.89
EPS
1.12
Reader sentiment Are you bullish or bearish on CLSK?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 4.15 Expensive vs history 92nd percentile
5-year average 1.79 · #74 of 93 in Capital Markets
P/E ratio -3.25 In line with history 60th percentile
5-year average 0.17 · forward -6.87
P/S ratio 4.65 In line with history 43rd percentile
5-year average 6.69 · forward 5.51 · #59 of 94 in Capital Markets

Vs. peers Capital Markets

Company Market cap P/E (TTM) P/B Div yield
CleanSpark (CLSK) 2.96B -3.05 3.89 0.00%
Morgan Stanley (MS) 297.95B 15.32 2.80 2.11%
Goldman Sachs (GS) 258.33B 13.70 2.35 1.92%
Charles Schwab (SCHW) 165.29B 17.41 3.76 1.23%
Robinhood (HOOD) 98.46B 48.46 10.39 0.00%
Interactive Brokers (IBKR) 39.75B 34.82 6.73 0.37%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value14.97 Economic moatNone UncertaintyVery High

Trading 29.9% below Morningstar's fair value estimate.

Fair value

Cleanspark Inc is assigned a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 16% discount to our quantitative fair value estimate of $14.97 per share; however, caution is warranted due to this estimate's very high uncertainty rating.

The company's balance sheet increases our fair value estimate. Low leverage mitigates financial risk, potentially boosting a firm's value. For example, the firm's current ratio of 5.9 sits in the top 10% globally. We have little concern about this company's ability to cover near-term obligations, thanks to its relatively high current ratio; this could be a compelling signal during times of distress, which contributes to our view that shares are undervalued.

Alternatively, the firm's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to market value ratio of 1.3, a core component of valuation, sits in the top 30% globally. The market value of equity is low relative to the business' enterprise value, suggesting the company could be buried in debt if anything goes wrong. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:00:20 · For reference only, not investment advice and not tailored to your situation.